HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$3.95
Day range
$3.98 - $4.45
Year range
$3.62 - $9.18
Market cap
31.56M USD
Avg Volume
25.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.54M | -3.73% |
Net income | -20.22M | 37.33% |
Net profit margin | — | — |
Earnings per share | -3.00 | 16.31% |
EBITDA | -21.32M | 24.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.24M | -34.33% |
Total assets | 144.68M | -34.60% |
Total liabilities | 27.77M | -17.52% |
Total equity | 116.92M | — |
Shares outstanding | 7.31M | — |
Price to book | 0.25 | — |
Return on assets | -34.94% | — |
Return on capital | -37.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -20.22M | 37.33% |
Cash from operations | -16.82M | 11.35% |
Cash from investing | 23.74M | -14.83% |
Cash from financing | 47.00K | -20.34% |
Net change in cash | 6.89M | -23.39% |
Free cash flow | -8.90M | -31.72% |
About
Founded
2015
Headquarters
Website
Employees
55
